• Most Popular
  • Most Shared

CombiMatrix, Clarient to market and sell cancer test

Thu Jan 31, 2008 6:23am EST

Stocks

   

Jan 31 (Reuters) - CombiMatrix Corp (CBMX.O) and Clarient Inc (CLRT.O) said they would jointly market and sell a cancer test called HemeScan.

Stocks

HemeScan test will be marketed by Clarient to pathologists, oncologists and patients, CombiMatrix said in a statement.

The HemeScan test is a comprehensive test which enables prognosis at the time of diagnosis in the treatment and care of chronic lymphocytic leukemia patients. (Reporting by Bhaswati Mukhopadhyay in Bangalore; Editing by Amitha Rajan)

Stocks


More from Reuters

Photo

Obama says U.S. will pursue plane attackers

KAILUA, Hawaii (Reuters) - A wing of al Qaeda claimed responsibility on Monday for a failed Christmas Day attack on a U.S.-bound passenger plane, and President Barack Obama vowed to bring "every element" of U.S. power against those who threaten Americans' safety. | Video

» More Top News
A young Kamchatka brown bear plays in its enclosure at the 'Tierpark Hagenbeck' zoo in Hamburg September 20, 2007. REUTERS/Christian Charisius

The return of the Russian bear

Jason Bush

As Russia's memories of crippling economic times fade, are reforms disappearing along with them?  Commentary 

Breakingviews
Surgeons extract the liver and kidneys of a brain-dead woman for organ transplant donation at the Unfallkrankenhaus Berlin (UKB) hospital in Berlin January 12, 2008. REUTERS/Fabrizio Bensch

Desperate, duped, or both

One of the world's largest organ trade hubs is moving to stop the living from cashing in their body parts.  Full Article 

Health